製品名:6-Chloro-N-cyclopentyl-1-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

IUPAC Name:[(2R,3R,4R,5R)-3,4-bis(acetyloxy)-5-[6-chloro-4-(cyclopentylamino)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]oxolan-2-yl]methyl acetate

CAS番号:2226740-87-8
分子式:C21H26ClN5O7
純度:95%+
カタログ番号:CM1075897
分子量:495.92

包装単位 有効在庫 価格(USD) 数量

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:2226740-87-8
分子式:C21H26ClN5O7
融点:-
SMILESコード:O(C(C)=O)[C@H]1[C@@H](O[C@H](COC(C)=O)[C@H]1OC(C)=O)N2C=3C(C=N2)=C(NC4CCCC4)N=C(Cl)N3
密度:
カタログ番号:CM1075897
分子量:495.92
沸点:
MDL番号:
保管方法:

Category Infos

Nucleosides and Nucleotides
Nucleosides consist of a nucleotide and a five-carbon sugar, and a nucleotide consists of a nucleotide, a five-carbon sugar, and one or more phosphate groups.
nucleoside manufacturer
As a professional nucleoside manufacturer, we can guarantee product quality and delivery time.our company has been committed to supply personalized product solutions to customers,pls consult us.

Column Infos

ORIC-533
ORIC-533 is a potential best-in-class, oral inhibitor of CD73 developed by ORIC Pharmaceuticals which is currently in a Ph. Ib trial for the treatment of relapsed/refractory multiple myeloma (MM). It inhibits the CD73-mediated conversion of AMP to adenosine which generates an immunosuppressive tumor microenvironment and has the potential to be a next-generation immunotherapy. The in-depth use of co-crystal structures led the team to discover a novel set of phosphonate bioisosteres which were able to achieve bioavailability for a highly polar scaffold. The structure and discovery story of ORIC-533 were recently presented at the ACS Spring 2024 Meeting in New Orleans.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.